- Reaction score
- 146
I guess we knew this was coming, but now we know for sure..."Similar to the week 18 primary endpoint results we reported in December of 2020, HST-001 did not achieve statistical significance at week 26 when compared to placebo."
They try to spin it as a win but...yeah, not so much.
Histogen Announces Week 26 HST-001 Study Results for the Treatment of Androgenic Alopecia in Men
HST-001 Found to be Safe and Well Tolerated with No Serious Adverse Events Planning Underway for Next Clinical Study in U.S. SAN DIEGO, Feb. 16, 2021 ...
www.globenewswire.com
They try to spin it as a win but...yeah, not so much.